Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Green Pine Capital Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 211
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 182
Rounds per year 8.79
Lead investments 38
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 9
Key employees 3
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Software
  • Health Care
  • Information Technology
  • Manufacturing
  • Biotechnology
Summary

Green Pine Capital Partners appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the Shenzhen. The company was established in Asia in China.

The important activity for fund was in 2018. Speaking about the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Green Pine Capital Partners is more than 1 billion dollars. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in 2-6 deals every year.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Green Pine Capital Partners, startups are often financed by Initial Capital, IDG Capital, FH Capital. The meaningful sponsors for the fund in investment in the same round are Lilly Asia Ventures, Yunqi Partners, Ventech China. In the next rounds fund is usually obtained by Warmsun Holding Group, Taishan Invest AG, Lilly Asia Ventures.

The overall number of key employees were 3.

The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight UBTech Robotics, Yaoshibang, MGI Tech. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Green Pine Capital Partners:
Typical Co-investors
Green Pine Capital Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Green Pine Capital Partners:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Baisios

Biotechnology
Genetics
Medical
01 Nov 2023 Fengtai, Beijing, China

Youyun

Cloud Computing
Information Technology
Software
$30M15 Sep 2023 Hangzhou, Zhejiang, China

Guorui Xiechuang

Energy
Energy Storage
$15M25 May 2023 Shenzhen, Guangdong, China

Shenzhen 01 Life Science and Technology

$15M21 Apr 2023 Shenzhen, Guangdong, China

Ruitai Biotechnology

Health Care
Medical
Medical Device
$13M09 Mar 2023 Ningbo, Zhejiang, China

Neuracle

Health Care
16 Dec 2022 China, Wuwei, China

Readline

Agriculture
Biotechnology
Pharmaceutical
$46M09 Dec 2022 Futian District, Guangdong Province, China

Angshi Smart

Electronics
Manufacturing
Robotics
05 Dec 2022 Guangdong, Tianjin, China

Gangdi Technology

Electronics
Manufacturing
Marketing Automation
16 Nov 2022 Wuhan, Hubei, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Green Pine Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 211
Average round size 30M
Rounds per year 8.79
Peak activity year 2016
Lead investments 38
Follow on index 0.14
Exits 9
Group Appearance index 0.70

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Baisios

Biotechnology
Genetics
Medical
01 Nov 2023 Fengtai, Beijing, China

Youyun

Cloud Computing
Information Technology
Software
$30M15 Sep 2023 Hangzhou, Zhejiang, China

Guorui Xiechuang

Energy
Energy Storage
$15M25 May 2023 Shenzhen, Guangdong, China

Shenzhen 01 Life Science and Technology

$15M21 Apr 2023 Shenzhen, Guangdong, China

Ruitai Biotechnology

Health Care
Medical
Medical Device
$13M09 Mar 2023 Ningbo, Zhejiang, China

Neuracle

Health Care
16 Dec 2022 China, Wuwei, China

Readline

Agriculture
Biotechnology
Pharmaceutical
$46M09 Dec 2022 Futian District, Guangdong Province, China

Angshi Smart

Electronics
Manufacturing
Robotics
05 Dec 2022 Guangdong, Tianjin, China

Gangdi Technology

Electronics
Manufacturing
Marketing Automation
16 Nov 2022 Wuhan, Hubei, China
Crunchbase icon

Content report

The following text will be sent to our editors: